Universitaetsklinikum Halle (Saale) AöR — Clinical Trial Site

107 Registered trials

41 Currently recruiting

Organisation

Universitaetsklinikum Halle (Saale) AöR

Location

Halle Saale, Germany

Identifier

ORG-100020201

Address

Kroellwitz, Ernst-Grube-Straße 40, Kröllwitz, 06120, Germany

Departments

"Innere Medizin I Gastroenterologie, Pneumologie"
#1202: Klinik und Poliklinik fuer Paediatrie I
#4004: Department für Orthopädie, Unfall- und Wiederherstellungschirurgie
#5005:Klinik für Innere Medizin IV, Hämatologie und Onkologie
2156:Klinik und Poliklinik für Innere Medizin II
49001: Klinik und Poliklinik für Pädiatrie I Pädiatrische Onkologie Interdisziplinäre Station IDS
Center for Reproductive Medicine and Andrology
Clinic and Polyclinic for Paediatrics I
Clinic for Internal Medicine IV
Dep. of Visceral, Vasculär and Endocrine Surgery
Department for Internal Medicine IV Hematology/Oncology/Hemostaseology
Department für Innere Medizin Innere Medizin I (Gastroenterologie, Pneumologie)
Department für Innere Medizin Klinik für Innere Medizin II
Department of Gynecology
Department of Hematology and Medical
Department of Internal Medicine I
Department of Internal Medicine IV, Hematology and Oncology
Department of Internal Medicine IV, Oncology and Hemostasis
Dermatologie und Venerologie
Dermatology
Hematology
Hematology and Oncology
Hematology oncology and hemostaseology
Innere Medizien IV, Hämatologie und Onkologie)
Innere Medizin I
Innere Medizin IV (Hämatologie und Onkologie)
Internal Medicine IV (Hematology and Oncology)
Internal Medicine, Hematology and Oncology
Klinik für Innere Medizin IV
Klinik für Innere Medizin I, (Gastroenterologie, Pneumologie)
Klinik für Innere Medizin IV
Klinik für Innere Medizin IV- Hämatologie/Onkologie
Klinik für Innere Medizin IV, Haematologie/Onkologie/Haemostaseologie
Klinik für Innere Medizin IV, Hämatologie und Onkologie
Klinik für Kinder- und Jugendmedizin - Pädiatrie I - Hämatologie und Onkologie
Klinik für Neurologie
Klinik und Poliklinik für Innere Medizin IV
Klinik und Poliklinik für Innere Medizin I
Klinik und Poliklinik für Innere Medizin II
Klinik und Poliklinik für Innere Medizin III, UK Halle
Klinik und Poliklinik für Pädiatrie
Klinik und Poliklinik für Pädiatrie I
Krukenberg-Cancer Center Halle
Krukenberg-Krebszentrum Halle (KKH)
Krukenberg-Krebszentrum Halle, Klinik für Innere Medizin IV, Hämatologie / Onkologie
Mitteldeutsches Herzzentrum, Universitätsklinik und Poliklinik für Herzchirurgie
N/A
NEUROMUSCULAR CENTER HALLE DEPARTMENT OF NEUROLOGY
Oncology
Oncology for pediatrics
Paediatric Oncology and Haematology
Paedriatrics, Department of Oncology and Hematology
Poliklinik fuer Dermatologie und Venerologie
Poliklinik fuer Innere Medizin I
Universitaetsklinik für Innere Medizin IV
Universitaetsklinik und Poliklinik fuer Urologie
Universitaetsklinik und Poliklink fuer Dermatologie und Venerologie
Universitätsklinik für Dermatologie und Venerologie
Universitätsklinik u. Poliklinik f. Gynäkologie
Universitätsklinik und Poliklinik für Viszeral-, Gefäß- und endokrine Chirurgie
Universitätsklinik und Poliklinik für Viszerale, Gefäß- und endokrine Chirurgie
Universitätsklinik und Poliklinik für Dermatologie und Venerologie
Universitätsklinik und Poliklinik für Gynäkologie
Universitätsklinik und Poliklinik für Innere Medizin I
Universitätsklinik und Poliklinik für Innere Medizin I - Schwerpunkt Pneumologie
Universitätsklinik und Poliklinik für Innere Medizin IV
Universitätsklinik und Poliklinik für Neurologie
Universitätsklinik und Poliklinik für Radiologie, Kinderradiologie
Universitätsklinik und Poliklinik für Urologie
Universitätsklinik und Poliklinik für Viszerale, Gefäß- und Endokrine Chirurgie
Universitätsklinik und Poliklinik für Viszerale, Gefäß- und Endokrine Chirurgie Universitätsklinikum
Universitätsklinikum Halle - Innere Medizin III
Universitätsklinikum Halle, Klinik und Poliklinik für Innere Medizin IV
University Clinic for Internal Medicine IV
University Hospital and Polyclinic for Internal Medicine IV
Urology

Clinical trials at this site (107)

Search interface

Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018 Ended

2022-501457-37-00 Myeloid Leukemia in Children with Down Syndrome 5 2024-10-28
A Phase 3, Randomized, Open-label, Multi-center Study Evaluating the Efficacy and Safety of TAR-200 Versus Investigator’s Choice of Intraves… Ended

2023-507685-10-00 High-Risk Non-muscle-invasive Bladder Cancer 5 2024-05-30
A clinical study of V940 treatment and pembrolizumab in people with bladder cancer (V940-005) Ended

2023-505658-17-00 Muscle-invasive Urothelial Carcinoma 4 2024-04-16
A Phase III multicenter study to evaluate the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythaemia patients Ended

2023-505160-12-00 Essential Thrombocythaemia 5 2023-12-04
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata (BRAVE-AA-PEDS) Ended

2022-502700-78-00 Alopecia areata (AA) 5 2023-09-01
The PRESTO Trial - Organ preservation with durvalumab-based immunotherapy in combination with chemoradiation as definitive therapy for early… Ended

2024-512980-29-00 T1-T2N0 esophageal adenocarcinoma including gastroesoph 4 2023-08-28
A prospective multicenter phase 2 study of the chemotherapy-light combination of intravenous rituximab with the antibody-drug conjugate pol… Ended

2024-513949-37-00 previously untreated aggressive B-cell lymphoma 4 2023-03-16
Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor Long-term Safety and Efficacy in Subjects Without F508del Ended

2024-515637-14-00 Cystic Fibrosis 5 2022-11-08
Treatment combination of Durvalumab, Tremelimumab, Enfortumab Vedotin in patients with muscle invasive bladder cancer ineligible to cisplati… Ended

2023-507342-84-00 Bladder Cancer 5 2021-10-26
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease … Ended

2023-506926-35-00 Atherosclerotic cardiovascular disease, chronic kidney 5 2021-09-24
The STARBOARD Study: Phase 3 Study of Encorafenib and Binimetinib Plus Pembrolizumab in BRAF V600E/K Mutation-Positive Metastatic or Unresec… Ended

2024-512038-13-00 Metastatic or unresectable locally advanced BRAF V600E/ 5 2021-09-16
Trial comparing the efficacy and safety of tafasitamab plus lenalidomide in addition to standard therapy versus standard therapy in patients… Ended

2022-500237-92-00 Newly-diagnosed high-intermediate and high-risk diffuse 5 2021-04-23
A Study of TL-895 in Myelofibrosis, Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome, or Non-Monoclonal Mast Cell Ac… Ended

2024-514467-26-00 Indolent Systemic Mastocytosis 4 2021-04-07
A study to evaluate the benefit and safety of Luspatercept (ACE-536) in adults with myeloproliferative neoplasm-associated myelofibrosis on … Ended

2023-507890-17-00 Anemia associated with myeloproliferative neoplasm (MPN 5 2021-02-22
KILT - A RANDOMIZED NON COMPARATIVE PHASE II STUDY OF LACUTAMAB WITH GEMOX VERSUS GEMOX ALONE IN RELAPSED/REFRACTORY PATIENTS WITH PERIPHERA… Ended

2024-513252-15-00 IN RELAPSED/REFRACTORY PATIENTS WITH PERIPHERAL T-CELL 4 2021-01-28
Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended

2023-510390-33-00 HER2-negative breast cancer patients with high relapse 5 2020-10-23
Long-term study to assess the safety and efficacy of Nemolizumab in subjects with Atopic Dermatitis Ended

2024-514404-13-00 Atopic Dermatitis 5 2020-10-01
A randomized, controlled, open-label, phase III-trial on Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing abemaciclib combi… Ended

2023-509242-35-00 HR+/HER2- early breast cancer 5 2020-07-23
RACE-trial: Neoadjuvant Radiochemotherapy versus Chemotherapy for Patients with Locally Advanced, Potentially Resectable Adenocarcinoma of t… Ended

2024-516271-32-00 Adenocarcinoma of the gastroesophageal junction (AEG ty 5 2020-06-03
IMMUWHY Ended

2023-508314-42-00 Advanced stage intrahepatic biliary tract cancer (BTC) 4 2020-02-27
A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previo… Ended

2024-511747-25-00 B-cell non-Hodgkin lymphoma (NHL) 4 2019-12-23
Copanlisib and Rituximab in Marginal Zone Lymphoma Patients - A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY (COUP-1) Ended

2022-500674-34-00 Marginal Zone Lymphoma 4 2019-11-04
Efficacy of first line Bortezomib, Rituximab, Ibrutinib (B-RI) for patients with treatment naive Waldenström’s Macroglobulinemia Ended

2022-500584-12-00 Waldenström’s Macroglobulinemia 4 2019-09-11
Comparison of therapies before stem cell transplantation in patients with higher risk MDS and oligoblastic AML Ended

2024-515375-35-00 Untreated patients with higher risk MDS and oligoblasti 4 2019-08-26